News

A panel organized by the FDA cast doubts on the safety of antidepressants during pregnancy — drawing ire from doctors who say ...
In some situations, employees undergoing serious medical issues request accommodations that would require extensive time away from work or ...
Revenue (GAAP) surged to $31.7 million, exceeding analysts’ expectations by 88.8% driven by strong ZURZUVAE growth. Net loss (GAAP) narrowed to $49.7 million. This revenue surge, exceeding analysts’ ...
That’s the promise behind a new innovation from Trellis Health: the first FDA-cleared, at-home postpartum lab panel designed ...
However, some have to deal with a great "enemy:" postpartum depression, a psychological blow after giving birth. Famous women ...
Todd Marinovich, former phenom QB-turned-cautionary tale, steps out from under his own myth in new book ...
At a meeting held by the Food and Drug Administration on July 21, 2025, a panel convened by the agency cast doubt on the ...
Given the Trump administration’s priorities and CMS’s recently announced strategy around evidence-based prevention and cost ...
What’s behind the rise in maternal mental health struggles? And more importantly, what can be done to help mothers dealing ...
A new Genomic Press Interview with Dr. David R. Rubinow explores the transformational effect of his discovery that women with ...